Karex: A Health-Care Stock with 30% Upside – Barron’s


Barron’s
Karex: A Health-Care Stock with 30% Upside
Barron’s
Nomura analyst Marcin Spiewak, a Karex bull, thinks the market is over-concerned about a rise in rubber prices this year, which is putting pressure on the stock's price short-term. He thinks the company can pass on any slight increase in raw material

Source: Dutch Caribbean News Karex: A Health-Care Stock with 30% Upside – Barron’s

LEAVE A REPLY